Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.

Callahan CL, Schwartz K, Corley DA, Ruterbusch JJ, Zhao WK, Shuch B, Graubard BI, Rothman N, Chow WH, Silverman DT, Purdue MP, Hofmann JN.

Cancer Causes Control. 2019 Nov 28. doi: 10.1007/s10552-019-01248-1. [Epub ahead of print]

PMID:
31782041
2.

Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Argirion I, Zarins KR, Ruterbusch JJ, Vatanasapt P, Sriplung H, Seymour EK, Rozek LS.

Cancer. 2019 Sep 16. doi: 10.1002/cncr.32517. [Epub ahead of print]

PMID:
31524955
3.

Employment Outcomes, Financial Burden, Anxiety, and Depression Among Caregivers of African American Cancer Survivors.

Hastert TA, Ruterbusch JJ, Nair M, Noor MI, Beebe-Dimmer JL, Schwartz K, Baird TE, Harper FWK, Thompson H, Schwartz AG.

J Oncol Pract. 2019 Sep 7:JOP1900410. doi: 10.1200/JOP.19.00410. [Epub ahead of print]

PMID:
31496392
4.

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.

Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Bolton A, Schwartz K, Schwartz AG, Heath E.

Cancer Med. 2019 Jun;8(6):3325-3335. doi: 10.1002/cam4.2092. Epub 2019 May 15.

5.

The Epidemiology of Cancer Among Homeless Adults in Metropolitan Detroit.

Holowatyj AN, Heath EI, Pappas LM, Ruterbusch JJ, Gorski DH, Triest JA, Park HK, Beebe-Dimmer JL, Schwartz AG, Cote ML, Schwartz KL.

JNCI Cancer Spectr. 2019 Mar;3(1):pkz006. doi: 10.1093/jncics/pkz006. Epub 2019 Mar 25.

6.

Case-control investigation of occupational lead exposure and kidney cancer.

Callahan CL, Friesen MC, Locke SJ, Dopart PJ, Stewart PA, Schwartz K, Ruterbusch JJ, Graubard BI, Chow WH, Rothman N, Hofmann JN, Purdue MP.

Occup Environ Med. 2019 Jul;76(7):433-440. doi: 10.1136/oemed-2018-105327. Epub 2019 Feb 13.

PMID:
30760604
7.

The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population.

Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK, Simon MS, Abrams J, Schwartz KL, Schwartz AG.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):666-674. doi: 10.1158/1055-9965.EPI-18-0123. Epub 2018 Nov 27.

PMID:
30482875
8.

Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.

Greenwald MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, Albrecht TL, Schwartz AG.

Cancer. 2019 Jan 15;125(2):269-277. doi: 10.1002/cncr.31798. Epub 2018 Nov 2.

PMID:
30387871
9.

Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis.

Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, Schiffer CA.

Cancer. 2019 Jan 1;125(1):135-143. doi: 10.1002/cncr.31738. Epub 2018 Oct 21.

PMID:
30343488
10.

Decision rule approach applied to estimate occupational lead exposure in a case-control study of kidney cancer.

Callahan CL, Locke SJ, Dopart PJ, Stewart PA, Schwartz K, Ruterbusch JJ, Graubard BI, Rothman N, Hofmann JN, Purdue MP, Friesen MC.

Am J Ind Med. 2018 Nov;61(11):901-910. doi: 10.1002/ajim.22912. Epub 2018 Oct 6.

11.

Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.

Park HK, Schildkraut JM, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy M, Crankshaw S, Funkhouser E, Moorman PG, Peters ES, Terry P, Wang F, Ruterbusch JJ, Schwartz AG, Cote ML.

Cancer Causes Control. 2018 Nov;29(11):1081-1091. doi: 10.1007/s10552-018-1082-4. Epub 2018 Sep 29.

12.

Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1452. doi: 10.1007/s12325-018-0767-0.

13.

Screening and follow-up for depression among Arab Americans.

Dallo FJ, Prabhakar D, Ruterbusch J, Schwartz K, Peterson EL, Liu B, Ahmedani BK.

Depress Anxiety. 2018 Dec;35(12):1198-1206. doi: 10.1002/da.22817. Epub 2018 Aug 12.

PMID:
30099819
14.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Shaik AN, Ruterbusch JJ, Abdulfatah E, Shrestha R, Daaboul MHDF, Pardeshi V, Visscher DW, Bandyopadhyay S, Ali-Fehmi R, Cote ML.

Breast Cancer Res. 2018 Aug 9;20(1):91. doi: 10.1186/s13058-018-1027-6.

15.

Renal cell carcinoma risk associated with lower intake of micronutrients.

Bock CH, Ruterbusch JJ, Holowatyj AN, Steck SE, Van Dyke AL, Ho WJ, Cote ML, Hofmann JN, Davis F, Graubard BI, Schwartz KL, Purdue MP.

Cancer Med. 2018 Aug;7(8):4087-4097. doi: 10.1002/cam4.1639. Epub 2018 Jul 2.

16.

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1438-1451. doi: 10.1007/s12325-018-0738-5. Epub 2018 Jun 26. Erratum in: Adv Ther. 2018 Aug 16;:.

17.

Diabetes Management Among Arab Americans Who Sought Care at a Large Metropolitan Hospital System in Michigan.

Dallo FJ, Ruterbusch JJ, McCullough JR, Sreedhar S, Schwartz K, Mulhem E.

J Immigr Minor Health. 2019 Jun;21(3):490-496. doi: 10.1007/s10903-018-0777-7.

PMID:
29943204
18.

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.

Levin RA, Lund ME, Truong Q, Wu A, Shore ND, Saltzstein DR, Concepcion RS, Paivanas TA, van Breda A, Beebe-Dimmer J, Ruterbusch JJ, Wissmueller S, Campbell DH, Walsh BJ.

Oncotarget. 2018 Apr 27;9(32):22359-22367. doi: 10.18632/oncotarget.25009. eCollection 2018 Apr 27.

19.

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.

Campbell DH, Lund ME, Nocon AL, Cozzi PJ, Frydenberg M, De Souza P, Schiller B, Beebe-Dimmer JL, Ruterbusch JJ, Walsh BJ.

PLoS One. 2018 Apr 19;13(4):e0196017. doi: 10.1371/journal.pone.0196017. eCollection 2018.

20.

Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM, Flanders SC, Barlev A, Fryzek JP, Quek RGW.

Cancer. 2018 May 15;124(10):2104-2114. doi: 10.1002/cncr.31299. Epub 2018 Mar 5.

21.

Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.

Holowatyj AN, Cote ML, Ruterbusch JJ, Ghanem K, Schwartz AG, Vigneau FD, Gorski DH, Purrington KS.

J Clin Oncol. 2018 Mar 1;36(7):652-658. doi: 10.1200/JCO.2017.74.5448. Epub 2018 Jan 17. Erratum in: J Clin Oncol. 2018 Apr 1;36(10):1054.

22.

Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.

Simon MS, Beebe-Dimmer JL, Hastert TA, Manson JE, Cespedes Feliciano EM, Neuhouser ML, Ho GYF, Freudenheim JL, Strickler H, Ruterbusch J, Barac A, Chlebowski R, Caan B.

Cancer. 2018 Apr 15;124(8):1798-1807. doi: 10.1002/cncr.31230. Epub 2018 Jan 16.

23.

Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.

Thakur MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, Beebe-Dimmer JL, Wozniak AJ.

J Thorac Oncol. 2018 Jan;13(1):46-53. doi: 10.1016/j.jtho.2017.09.1964. Epub 2017 Oct 5.

24.

Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes.

Park HK, Ruterbusch JJ, Cote ML.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1511-1518. doi: 10.1158/1055-9965.EPI-17-0290. Epub 2017 Jul 27.

25.

Leukocyte telomere length and renal cell carcinoma survival in two studies.

Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, Hofmann JN, Purdue MP.

Br J Cancer. 2017 Aug 22;117(5):752-755. doi: 10.1038/bjc.2017.237. Epub 2017 Jul 25.

26.

Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.

Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS.

Breast Cancer Res Treat. 2017 Aug;165(1):163-168. doi: 10.1007/s10549-017-4300-y. Epub 2017 May 25.

27.

Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.

Daum LM, Reamer EN, Ruterbusch JJ, Liu J, Holmes-Rovner M, Xu J.

J Am Board Fam Med. 2017 May-Jun;30(3):288-297. doi: 10.3122/jabfm.2017.03.160298.

28.

Antihypertensive medication use and risk of renal cell carcinoma.

Colt JS, Hofmann JN, Schwartz K, Chow WH, Graubard BI, Davis F, Ruterbusch J, Berndt S, Purdue MP.

Cancer Causes Control. 2017 Apr;28(4):289-297. doi: 10.1007/s10552-017-0857-3. Epub 2017 Feb 21.

29.

Active surveillance for low-risk localized prostate cancer: what do men and their partners think?

Mallapareddi A, Ruterbusch J, Reamer E, Eggly S, Xu J.

Fam Pract. 2017 Feb;34(1):90-97. doi: 10.1093/fampra/cmw123. Epub 2016 Dec 29.

PMID:
28034917
30.

Occupational exposure to chlorinated solvents and kidney cancer: a case-control study.

Purdue MP, Stewart PA, Friesen MC, Colt JS, Locke SJ, Hein MJ, Waters MA, Graubard BI, Davis F, Ruterbusch J, Schwartz K, Chow WH, Rothman N, Hofmann JN.

Occup Environ Med. 2017 Mar;74(4):268-274. doi: 10.1136/oemed-2016-103849. Epub 2016 Nov 1.

31.

Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040.

Gaber C, Meza R, Ruterbusch JJ, Cote ML.

J Racial Ethn Health Disparities. 2016 Oct 17. [Epub ahead of print]

PMID:
27753051
32.

A Health Profile of Arab Americans in Michigan: A Novel Approach to Using a Hospital Administrative Database.

Dallo FJ, Ruterbusch JJ, Kirma JD, Schwartz K, Fakhouri M.

J Immigr Minor Health. 2016 Dec;18(6):1449-1454.

PMID:
26472547
33.

Cancer incidence trends using American Community Survey estimates are not consistent with SEER for small populations.

Mantey J, Ruterbusch J, Meza R, Schwartz K.

Cancer Epidemiol. 2016 Aug;43:87-91. doi: 10.1016/j.canep.2016.06.014. Epub 2016 Jul 13.

34.

HER2 status and disparities in luminal breast cancers.

Holowatyj AN, Ruterbusch JJ, Ratnam M, Gorski DH, Cote ML.

Cancer Med. 2016 Aug;5(8):2109-16. doi: 10.1002/cam4.757. Epub 2016 Jun 1.

35.

Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.

Xu J, Janisse J, Ruterbusch JJ, Ager J, Liu J, Holmes-Rovner M, Schwartz KL.

Ann Fam Med. 2016 May;14(3):208-14. doi: 10.1370/afm.1926.

36.

Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer.

Holowatyj AN, Ruterbusch JJ, Rozek LS, Cote ML, Stoffel EM.

J Clin Oncol. 2016 Jun 20;34(18):2148-56. doi: 10.1200/JCO.2015.65.0994. Epub 2016 May 2.

37.

Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.

Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS.

Int J Cancer. 2016 Aug 1;139(3):584-92. doi: 10.1002/ijc.30108. Epub 2016 Apr 9.

38.

Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.

Xu J, Janisse J, Ruterbusch J, Ager J, Schwartz KL.

J Racial Ethn Health Disparities. 2016 Mar;3(1):35-45. doi: 10.1007/s40615-015-0109-8. Epub 2015 May 5.

PMID:
26896103
39.

Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.

Schwartz K, Ruterbusch JJ, Colt JS, Miller DC, Chow WH, Purdue MP.

Cancer Med. 2016 Feb;5(2):200-8. doi: 10.1002/cam4.578. Epub 2015 Dec 29.

40.

Contribution of health behaviors to the association between area-level socioeconomic status and cancer mortality.

Hastert TA, Ruterbusch JJ, Beresford SA, Sheppard L, White E.

Soc Sci Med. 2016 Jan;148:52-8. doi: 10.1016/j.socscimed.2015.11.023. Epub 2015 Nov 22.

41.

Can problematic fibroepithelial lesions be accurately classified on core needle biopsies?

Bandyopadhyay S, Barak S, Hayek K, Thomas S, Saeed H, Beydoun R, Shi D, Arabi H, Ruterbusch J, Cote M, Ali-Fehmi R.

Hum Pathol. 2016 Jan;47(1):38-44. doi: 10.1016/j.humpath.2015.09.001. Epub 2015 Sep 21.

PMID:
26521710
42.

A case-control study of occupational sunlight exposure and renal cancer risk.

Karami S, Colt JS, Stewart PA, Schwartz K, Davis FG, Ruterbusch JJ, Chow WH, Wacholder S, Graubard BI, Purdue MP, Moore LE.

Int J Cancer. 2016 Apr 1;138(7):1626-33. doi: 10.1002/ijc.29902. Epub 2015 Nov 14.

43.

The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1407-15. doi: 10.1158/1055-9965.EPI-15-0316. Epub 2015 Aug 19.

44.

Racial differences in breast cancer survival in a large urban integrated health system.

Roseland ME, Pressler ME, Lamerato LE, Krajenta R, Ruterbusch JJ, Booza JC, Schwartz K, Simon MS.

Cancer. 2015 Oct 15;121(20):3668-75. doi: 10.1002/cncr.29523. Epub 2015 Jun 25.

45.

Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).

Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, Nicholson WK, Park AB, Petruzella S, Rebbeck TR, Setiawan VW, Signorello LB, Simon MS, Weiss NS, Wentzensen N, Yang HP, Zeleniuch-Jacquotte A, Olson SH.

Cancer Causes Control. 2015 Feb;26(2):287-296. doi: 10.1007/s10552-014-0510-3. Epub 2014 Dec 23.

46.

Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.

Ahmed QF, Gattoc L, Al-Wahab Z, Abdulfatah E, Ruterbusch JJ, Cote M, Bandyopadhyay S, Morris RT, Ali-Fehmi R.

Am J Surg Pathol. 2015 Feb;39(2):221-6. doi: 10.1097/PAS.0000000000000361.

PMID:
25517962
47.

Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML.

Breast J. 2014 Nov-Dec;20(6):571-7. doi: 10.1111/tbj.12331. Epub 2014 Sep 8.

48.

The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036. Epub 2014 Jun 19.

49.

Cancer incidence among Arab Americans in California, Detroit, and New Jersey SEER registries.

Bergmans R, Soliman AS, Ruterbusch J, Meza R, Hirko K, Graff J, Schwartz K.

Am J Public Health. 2014 Jun;104(6):e83-91. doi: 10.2105/AJPH.2014.301954. Epub 2014 Apr 17.

50.

Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.

Powell IJ, Vigneau FD, Bock CH, Ruterbusch J, Heilbrun LK.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1505-11. doi: 10.1158/1055-9965.EPI-13-1328. Epub 2014 May 6.

Supplemental Content

Loading ...
Support Center